Allergan, Inc. (AGN) · page 107 of 110
This slide is part of a larger activist presentation critiquing Valeant's accounting practices.
Activist deck · appendix_disclosure · expose_contradiction · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 2/2 list 2/2 title 1/1
Components 5
primary primary bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.